Patent details

Basic Information

Publication number:

EP2275110

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101826329

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Cladribine regimen for treating Multiple Sclerosis

French Title of Invention:

Régime posologique de cladribine pour le traitement de la sclérose en plaques

German Title of Invention:

Cladribin Dosierschema zur Behandlung von multipler Sklerose

SPC Number:

Dates

Filing date:

20/12/2005

Grant date:

10/07/2013

EP Publication Date:

10/07/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/01/2011

EP B1 Publication Date:

10/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/12/2014

Expiration date:

20/12/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2005

 

 

Name:

Merck Serono SA

Address:

Centre Industriel, 1267 Coinsins, Vaud, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/07/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Lopez-Bresnahan Maria

Address:

United States (US)

2

Name:

Munafo Alain

Address:

Switzerland (CH)

3

Name:

De Luca Giampiero

Address:

Switzerland (CH)

4

Name:

Ythier Arnoud

Address:

Switzerland (CH)

Priority

1

Priority Number:

638669 P

Priority Date:

22/12/2004

Priority Country:

United States (US)

2

Priority Number:

04106909

Priority Date:

22/12/2004

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/7076;

Filing date	Document type	Number of pages